Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection

Tuberculosis

Volumn 111, Issue , 2018, Pages 147-153

  Petrone, Linda ^a   Vanini, Valentina ^a   Chiacchio, Teresa ^a   Petruccioli, Elisa ^a   Cuzzi, Gilda ^a   Schininà, Vincenzo ^a   Palmieri, Fabrizio ^a   Ippolito, Giuseppe ^a   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Diagnosis; Inflammation; IP 10; LTBI; Quantiferon plus; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; CXCL10 PROTEIN, HUMAN; IFNG PROTEIN, HUMAN;

ADULT; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FEMALE; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PROCEDURES; REPRODUCIBILITY;

ADULT; BACTERIAL LOAD; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 85048710539     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2018.06.005     Document Type: Article

References (41)

1. WHO, Global tuberculosis report., 2017 www.who.int/tb/publications/global_report/en/2017.
2. Goletti, D., Sanduzzi, A., Delogu, G., Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl 91 (2014), 24–31.
3. Lalvani, A., Pareek, M., A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 93 (2010), 69–84.
4. Arend, S.M., Thijsen, S.F., Leyten, E.M., Bouwman, J.J., Franken, W.P., Koster, B.F., et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175 (2007), 618–627.
5. Menzies, D., Pai, M., Comstock, G., Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146 (2007), 340–354.
6. Petruccioli, E., Scriba, T.J., Petrone, L., Hatherill, M., Cirillo, D.M., Joosten, S.A., et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J 48 (2016), 1751–1763.
7. Petruccioli, E., Vanini, V., Chiacchio, T., Cuzzi, G., Cirillo, D.M., Palmieri, F., et al. Analytical evaluation of QuantiFERON- plus and QuantiFERON- gold in-tube assays in subjects with or without tuberculosis. Tuberculosis (Edinb) 106 (2017), 38–43.
8. Barcellini, L., Borroni, E., Brown, J., Brunetti, E., Codecasa, L., Cugnata, F., et al. First independent evaluation of QuantiFERON-TB Plus performance. Eur Respir J 47 (2016), 1587–1590.
9. Boom, W.H., Canaday, D.H., Fulton, S.A., Gehring, A.J., Rojas, R.E., Torres, M., Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb) 83 (2003), 98–106.
10. Busch, M., Herzmann, C., Kallert, S., Zimmermann, A., Hofer, C., Mayer, D., et al. Lipoarabinomannan-responsive polycytotoxic T cells are associated with protection in human tuberculosis. Am J Respir Crit Care Med 194 (2016), 345–355.
11. Brookes, R.H., Pathan, A.A., McShane, H., Hensmann, M., Price, D.A., Hill, A.V., CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages. Eur J Immunol 33 (2003), 3293–3302.
12. Turner, J., Dockrell, H.M., Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 87 (1996), 339–342.
13. Chiacchio, T., Petruccioli, E., Vanini, V., Cuzzi, G., Pinnetti, C., Sampaolesi, A., et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect 69 (2014), 533–545.
14. Nikolova, M., Markova, R., Drenska, R., Muhtarova, M., Todorova, Y., Dimitrov, V., et al. Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis 75 (2013), 277–281.
15. Rozot, V., Patrizia, A., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C.L., et al. Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clin Infect Dis 60 (2015), 432–437.
16. Rozot, V., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C.L., Perreau, M., et al. Mycobacterium tuberculosis-specific CD8 T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 43 (2013), 1568–1577.
17. Petruccioli, E., Chiacchio, T., Pepponi, I., Vanini, V., Urso, R., Cuzzi, G., et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus. J Infect 73 (2016), 588–597.
18. Goletti, D., Lee, M.R., Wang, J.Y., Walter, N., Ottenhoff, T.H.M., Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease. Respirology 23 (2018), 455–466.
19. Telisinghe, L., Amofa-Sekyi, M., Maluzi, K., Kaluba-Milimo, D., Cheeba-Lengwe, M., Chiwele, K., et al. The sensitivity of the QuantiFERON(®)-TB Gold Plus assay in Zambian adults with active tuberculosis. Int J Tubercul Lung Dis 21 (2017), 690–696.
20. Ruhwald, M., Dominguez, J., Latorre, I., Losi, M., Richeldi, L., Pasticci, M.B., et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 91 (2011), 260–267.
21. Ruhwald, M., Bodmer, T., Maier, C., Jepsen, M., Haaland, M.B., Eugen-Olsen, J., et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32 (2008), 1607–1615.
22. Ruhwald, M., Petersen, J., Kofoed, K., Nakaoka, H., Cuevas, L.E., Lawson, L., et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One, 3, 2008, e2858.
23. Ruhwald, M., Aabye, M.G., Ravn, P., IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 12 (2012), 175–187.
24. Goletti, D., Raja, A., Ahamed Kabeer, B.S., Rodrigues, C., Sodha, A., Butera, O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 61 (2010), 133–143.
25. Petrone, L., Cannas, A., Vanini, V., Cuzzi, G., Aloi, F., Nsubuga, M., et al. Blood and urine inducible protein 10 as potential markers of disease activity. Int J Tubercul Lung Dis 20 (2016), 1554–1561.
26. Petrone, L., Cannas, A., Aloi, F., Nsubuga, M., Sserumkuma, J., Nazziwa, R.A., et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. BioMed Res Int, 2015, 2015, 589471.
27. Vanini, V., Petruccioli, E., Gioia, C., Cuzzi, G., Orchi, N., Rianda, A., et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect 65 (2012), 49–59.
28. Yassin, M.A., Petrucci, R., Garie, K.T., Harper, G., Teshome, A., Arbide, I., et al. Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection. Eur Respir J 41 (2013), 644–648.
29. Azzurri, A., Sow, O.Y., Amedei, A., Bah, B., Diallo, S., Peri, G., et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microb Infect 7 (2005), 1–8.
30. Chegou, N.N., Detjen, A.K., Thiart, L., Walters, E., Mandalakas, A.M., Hesseling, A.C., et al. Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One, 8, 2013, e64226.
31. Petrucci, R., Abu Amer, N., Gurgel, R.Q., Sherchand, J.B., Doria, L., Lama, C., et al. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 27 (2008), 1073–1077.
32. Kabeer, B.S., Sikhamani, R., Raja, A., Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn Microbiol Infect Dis 71 (2011), 236–243.
33. Cannas, A., Calvo, L., Chiacchio, T., Cuzzi, G., Vanini, V., Lauria, F.N., et al. IP-10 detection in urine is associated with lung diseases. BMC Infect Dis, 2010 doi: 10.333,2334-10-333.
34. Day, C.L., Abrahams, D.A., Lerumo, L., Janse van Rensburg, E., Stone, L., O'rie, T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 187 (2011), 2222–2232.
35. Petrone, L., Chiacchio, T., Vanini, V., Petruccioli, E., Cuzzi, G., Di Giacomo, C., et al. High urine IP-10 levels associate with chronic HCV infection. J Infect 68 (2014), 591–600.
36. Aabye, M.G., Ruhwald, M., Praygod, G., Jeremiah, K., Faurholt-Jepsen, M., Faurholt-Jepsen, D., et al. Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 36 (2010), 1488–1490.
37. Chen, D.Y., Shen, G.H., Chen, Y.M., Chen, H.H., Lin, C.C., Hsieh, C.W., et al. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Int J Tubercul Lung Dis 15 (2011), 192–200.
38. Villar-Hernandez, R., Latorre, I., Minguez, S., Diaz, J., Garcia-Garcia, E., Muriel-Moreno, B., et al. Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases. J Infect 75 (2017), 315–325.
39. Aabye, M.G., Eugen-Olsen, J., Werlinrud, A.M., Holm, L.L., Tuuminen, T., Ravn, P., et al. A simple method to quantitate IP-10 in dried blood and plasma spots. PLoS One, 7, 2012, e39228.
40. Aabye, M.G., Latorre, I., Diaz, J., Maldonado, J., Mialdea, I., Eugen-Olsen, J., et al. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J 42 (2013), 495–503.
41. Ruhwald, M., Andersen, E.S., Christensen, P.B., Moessner, B.K., Weis, N., IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection. PLoS One, 7, 2012, e45181.